Stereotactic Body Radiation Therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience

Table 3 Prevalence of CTC graded gastrointestinal (GI) and genitourinary (GU) toxicities at each follow-up

Follow-up (months)		1	3	6	9	12	18	24
Toxicity	Grade	%	%	%	%	%	%	%
Bowel Frequency/Urgency	0	72	83	78	81	91	95	93
	1	23	16	20	18	8	5	7
	2	5	1	1	1	1	0	0
Proctitis	0	86	97	95	95	99	99	100
	1	14	3	5	5	1	1	0
	2	0	0	0	0	0	0	0
Rectal Bleeding	0	94	98	96	95	98	93	96
Rectal Bleeding	1	6	2	4	5	2	7	4
	2	0	0	0	0	0	0	0
Highest GI	0	60	79	71	73	87	89	89
	1	35	20	28	26	12	11	11
	2	5	1	1	1	1	0	0
Hematuria	0	96	97	99	96	97	98	94
	1	4	2	0	3	2	1	4
	2	0	1	0	0	0	0	0
	3	0	0	1	1	1	1	1
Dysuria	0	71	91	97	88	93	96	93
	1	29	9	3	13	7	4	7
	2	0	0	0	0	0	0	0
Incontinence	0	85	86	86	84	89	89	88
	1	13	14	14	16	11	10	12
	2	2	0	0	0	0	1	0
Urinary Frequency/Urgency	0	81	90	90	93	93	90	88
	1	19	10	9	7	6	8	11
	2	0	0	1	0	1	2	1
Retention	0	55	64	63	70	75	70	76
	1	10	11	14	11	9	11	9
	2	35	24	23	19	16	19	16
Highest GU	0	28	52	53	54	59	53	57
	1	36	23	23	26	23	26	26
	2	35	25	23	19	17	20	17
	3	0	0	1	1	1	1	1

ISSN: 1748-717X